IVI’s MISSION is to advance the science and improve the practice of value assessment in healthcare.
IVI’s GOAL is to build a platform that facilitates robust and rigorous patient-centered value assessment of health technologies tailored to the needs and interests of individual decision makers.
The Value Debate
Scientific, technological, and clinical advances are driving a revolution in patient care – but spending on healthcare also continues to increase. Most observers agree that change is needed in order to link healthcare spending to value rather than volume, but determining how to make this link quickly leads to debate and disagreement. What defines value? Value to whom? And how do we measure it?
A New Approach
The Innovation and Value Initiative (IVI) was created to raise the level of discussion regarding value in healthcare and find common ground in the approach to measuring value. The U.S health system is diverse, complex, and ripe for innovation. IVI brings together healthcare leaders from academia, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and patient communities to advance approaches to value that fit the American context.
Patients are likely to continue to be asked to take more responsibility for their healthcare…it is time to shift the discussion toward helping patients understand what value actually means in choosing their health care and discharging their financial responsibilities.
At the 2019 ISPOR conference, Jeroen Jansen sat down with AJMC to explain the current state of value assessment and how by putting patients at the frontend of analysis, we can better quantify the value [...]
Devin Incerti sat down with the AJMC media team at the 2019 ISPOR conference to discuss how value is context-specific and therefore value assessment should be too. Watch the interview here.
In a new Value Blueprints research brief, IVI explores the novel concept of “Insurance Value.” New medical technologies not only benefit patients, but also healthy people at risk of future illness. The insurance value arising [...]